Literature DB >> 16079146

Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions.

Jürgen Zschocke1, Nadhim Bayatti, Albrecht M Clement, Heidrun Witan, Maciej Figiel, Jürgen Engele, Christian Behl.   

Abstract

Steroids that activate glucocorticoid receptors (GRs) and mineralocorticoid receptors have important regulatory effects on neural development, plasticity, and the body's stress response. Here, we investigated the role of corticosteroids in regulating the expression of the glial glutamate transporters glial glutamate transporter-1 (GLT-1) and glutamate-aspartate transporter (GLAST) in rat primary astrocytes. The synthetic glucocorticoid dexamethasone provoked a marked increase of GLT-1 transcription and protein levels in cortical astrocytes, whereas GLAST expression remained unaffected. Up-regulation of GLT-1 expression was accompanied by an enhanced glutamate uptake, which could be blocked by the specific GLT-1 inhibitor dihydrokainate. The promoting effect of dexamethasone on GLT-1 gene expression and function was abolished by the GR antagonist mifepristone. A predominant role of the GR was further supported by the observation that corticosterone could elevate GLT-1 expression in a dose-dependent manner, whereas aldosterone, the physiological ligand of the mineralocorticoid receptor, exerted only weak effects even when applied at high concentrations. Moreover, we monitored brain region-specific differences, since all corticosteroids used in this study failed to alter the expression of GLT-1 in midbrain and cerebellar glia, although expression levels of both corticosteroid receptor subtypes were similar in all brain regions analyzed. Dexamethasone, however, modestly enhanced GLT-1 expression in cerebellar glia in combination with the DNA methyltransferase inhibitor 5-aza-2-deoxycytidine, suggesting that suppression of GLT-1 expression in cerebellar cultures may at least in part be epigenetically mediated by a DNA methylation-dependent process. Taken together, our data highlight a potential role for glucocorticoids in regulating GLT-1 gene expression during central nervous system development or pathophysiological processes including stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079146     DOI: 10.1074/jbc.M502581200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Responses of glial cells to stress and glucocorticoids.

Authors:  F Jauregui-Huerta; Y Ruvalcaba-Delgadillo; R Gonzalez-Castañeda; J Garcia-Estrada; O Gonzalez-Perez; S Luquin
Journal:  Curr Immunol Rev       Date:  2010-08-01

2.  Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

Authors:  Andrew B Stergachis; Jonai Pujol-Giménez; Gergely Gyimesi; Daniel Fuster; Giusppe Albano; Marina Troxler; Jonathan Picker; Paul A Rosenberg; Ann Bergin; Jurriaan Peters; Christelle Moufawad El Achkar; Chellamani Harini; Shannon Manzi; Alexander Rotenberg; Matthias A Hediger; Lance H Rodan
Journal:  Ann Neurol       Date:  2019-04-26       Impact factor: 10.422

Review 3.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

Review 4.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

5.  Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro.

Authors:  Bradley S Carter; Fan Meng; Robert C Thompson
Journal:  Physiol Genomics       Date:  2012-10-30       Impact factor: 3.107

Review 6.  Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Michael Aschner; Eunsook Y Lee
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

Review 7.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

8.  Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal.

Authors:  Ronald Kim; Marian T Sepulveda-Orengo; Kati L Healey; Emily A Williams; Kathryn J Reissner
Journal:  Neuropharmacology       Date:  2017-09-14       Impact factor: 5.250

9.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16

10.  Recent advances in the treatment of pain.

Authors:  Mellar P Davis
Journal:  F1000 Med Rep       Date:  2010-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.